Prescription Required
Formulation: Tablet
Prescription Required
Formulation: Tablet
(Generic Alternative)
Select the prescribed dosage
Select the quantity to see the price.
* This price includes a dispensing fee, medical review fee, and packing fee.
Shipped and delivered directly to your doorstep
Lodosyn (carbidopa) is a prescription medication used together with levodopa to help manage symptoms of Parkinson’s disease and certain forms of parkinsonism.
It contains carbidopa, a medication that belongs to a class of drugs called peripheral dopa decarboxylase inhibitors.
Lodosyn works by preventing levodopa from being converted into dopamine before it reaches the brain. This allows more levodopa to enter the brain, where it can be converted into dopamine and help improve movement-related symptoms.
Dopamine is a chemical messenger that helps the brain control movement, coordination, and muscle activity.
People with Parkinson’s disease have reduced dopamine activity in certain areas of the brain, which contributes to symptoms such as tremors, stiffness, and slow movement.
Lodosyn helps make levodopa treatment more effective and may reduce nausea and vomiting associated with levodopa therapy.
Lodosyn must be taken with levodopa or a carbidopa-levodopa combination medication. Carbidopa alone does not provide meaningful relief from Parkinson’s symptoms because it does not directly increase dopamine levels in the brain.
Lodosyn is used in combination with levodopa to help manage symptoms of Parkinson’s disease.
Parkinson’s disease is a progressive neurological disorder that affects the brain’s ability to control movement.
It develops when nerve cells responsible for producing dopamine become damaged or gradually die.
As dopamine levels decrease, communication between brain regions involved in movement becomes less effective.
This can lead to several movement-related symptoms, including:
Levodopa helps relieve these symptoms by entering the brain and being converted into dopamine.
However, when levodopa is taken alone, much of it may be converted into dopamine before reaching the brain.
This reduces the amount of medication available to relieve Parkinson’s symptoms and can cause side effects such as nausea and vomiting.
Lodosyn helps prevent this early conversion, allowing more levodopa to reach the brain.
As a result, patients may experience improved symptom control while requiring less levodopa than they would without carbidopa.
Lodosyn does not cure Parkinson’s disease or stop its progression. Its role is to support levodopa treatment and help manage symptoms.
One important use of Lodosyn is to reduce nausea and vomiting associated with levodopa therapy.
Levodopa can cause nausea when it is converted into dopamine outside the brain.
This dopamine can stimulate areas involved in triggering nausea and vomiting.
Carbidopa blocks much of this conversion in tissues outside the brain, which helps reduce these unwanted effects.
Some patients receive additional Lodosyn when their existing carbidopa-levodopa medication does not provide enough carbidopa to adequately control nausea.
This may make levodopa treatment easier to tolerate and allow healthcare providers to adjust the levodopa dose more effectively.
However, Lodosyn does not guarantee that nausea or vomiting will disappear completely.
Your healthcare provider will determine whether additional carbidopa is appropriate based on your current medications, symptoms, and treatment response.
Lodosyn may also be used with levodopa to treat certain forms of parkinsonism.
Parkinsonism is a term describing a group of neurological symptoms that resemble Parkinson’s disease.
These symptoms may include tremors, muscle stiffness, slow movement, and difficulty maintaining balance.
Although Parkinson’s disease is the most common cause of parkinsonism, similar symptoms may develop from other neurological conditions or injuries.
Lodosyn is specifically indicated for use with levodopa in certain forms of parkinsonism, including postencephalitic parkinsonism and symptomatic parkinsonism associated with particular toxic exposures.Â
Postencephalitic parkinsonism is a condition that may develop after encephalitis, which is inflammation of the brain.
In some cases, inflammation or damage to brain regions involved in movement can produce symptoms similar to Parkinson’s disease.
These may include muscle stiffness, tremors, slow movement, and difficulty walking.
When levodopa is considered appropriate, Lodosyn may be prescribed to help improve how much levodopa reaches the brain.
This may support better management of movement-related symptoms.
However, treatment response varies depending on the underlying neurological damage.
Some forms of parkinsonism can develop after damage to the nervous system caused by exposure to toxic substances.
Examples include carbon monoxide poisoning and excessive manganese exposure.
Carbon monoxide is a poisonous gas that interferes with the body’s ability to deliver oxygen to tissues.
Severe exposure may damage parts of the brain involved in movement.
Manganese is a mineral needed in small amounts, but excessive occupational or environmental exposure can damage neurological structures involved in motor control.
These conditions may cause symptoms resembling Parkinson’s disease, such as muscle stiffness, slow movement, and walking difficulties.
Lodosyn may be used with levodopa when a healthcare provider determines that dopamine replacement treatment could be beneficial.
However, not every form of toxin-related parkinsonism responds well to levodopa.
The effectiveness of treatment depends on the cause and extent of neurological damage.
Lodosyn works by blocking an enzyme called aromatic L-amino acid decarboxylase, also known as dopa decarboxylase.
This enzyme converts levodopa into dopamine.
Levodopa is a medication that can cross the blood-brain barrier, a protective system that controls which substances can move from the bloodstream into the brain.
Dopamine itself cannot readily cross this barrier.
For this reason, levodopa is used to increase dopamine levels in the brain.
However, dopa decarboxylase is present both inside and outside the brain.
Without sufficient carbidopa, a substantial amount of levodopa may be converted into dopamine in peripheral tissues before it reaches the brain.
Carbidopa helps prevent this process.
Prevents Levodopa Breakdown Outside the Brain
Lodosyn inhibits dopa decarboxylase in peripheral tissues, meaning tissues outside the brain.
This reduces the conversion of levodopa into dopamine in areas such as the digestive system and bloodstream.
Because less levodopa is converted outside the brain, more remains available to enter the central nervous system.
This is important because levodopa must reach the brain before it can effectively relieve Parkinson’s movement symptoms.
Allows More Levodopa to Reach the Brain
By reducing peripheral levodopa conversion, carbidopa increases the amount of levodopa available for transport into the brain.
Once levodopa crosses the blood-brain barrier, it can be converted into dopamine.
This helps restore dopamine activity in brain regions involved in movement control.
As dopamine activity improves, symptoms such as stiffness, tremors, and slow movement may become easier to manage.
Carbidopa does not significantly cross the blood-brain barrier. Therefore, it mainly acts outside the brain and does not prevent levodopa from being converted into dopamine where it is needed.Â
Helps Reduce the Required Levodopa Dose
Carbidopa allows more levodopa to reach the brain instead of being converted into dopamine in peripheral tissues.
Because more levodopa becomes available for its intended action, a lower levodopa dose may produce a therapeutic response comparable to a higher dose taken without carbidopa.
This can help reduce certain unwanted effects associated with peripheral dopamine production.
However, the exact levodopa dose required varies between patients.
Your healthcare provider will adjust treatment according to symptom control, side effects, and overall response.
Helps Reduce Levodopa-Related Nausea
Levodopa-related nausea and vomiting can occur when dopamine is produced outside the brain.
By reducing peripheral dopamine formation, carbidopa helps limit this effect.
As a result, patients may tolerate levodopa treatment better.
For some people, additional carbidopa allows their healthcare provider to increase levodopa more gradually or reach an effective treatment dose more comfortably.
However, carbidopa does not eliminate all levodopa-related side effects.Â
Lodosyn is intended to support levodopa treatment rather than replace it.
Levodopa is the ingredient that enters the brain and is converted into dopamine.
Carbidopa helps ensure that more levodopa reaches the brain before being converted.
Together, they provide a more efficient approach to increasing dopamine activity in the nervous system.
Many Parkinson’s medications already contain both carbidopa and levodopa in a single tablet.
However, some patients may need additional carbidopa.
For example, a healthcare provider may prescribe Lodosyn if the amount of carbidopa in a patient’s combination medication is insufficient to control levodopa-related nausea.
In other cases, separate carbidopa tablets may be used when the healthcare provider needs to adjust the amounts of carbidopa and levodopa independently.
Lodosyn should never be used alone to treat Parkinson’s disease or parkinsonism.
Lodosyn begins affecting levodopa metabolism after it is taken with levodopa.
However, the time needed to notice improvements depends on the levodopa formulation, dosage schedule, and individual treatment response.
Some patients may notice improved tolerability or changes in symptom control after their medication regimen is adjusted.
The full benefit of a treatment adjustment may require additional monitoring and dose changes.
Lodosyn does not directly relieve Parkinson’s symptoms on its own.
Instead, it supports the action of levodopa by reducing its conversion into dopamine outside the brain.
Your healthcare provider will evaluate your response to the combined treatment and make adjustments when necessary.
Lodosyn is available as an oral tablet containing 25 mg of carbidopa.
It must be taken with levodopa or a carbidopa-levodopa medication as prescribed.
Do not begin, stop, or change your Parkinson’s medications without consulting your healthcare provider.
Suddenly reducing or discontinuing levodopa-containing treatment can cause serious complications, including severe muscle stiffness, fever, and changes in consciousness.
Tell your healthcare provider about your complete medication history, including treatments for blood pressure, mood disorders, and other neurological conditions.
Some medications may interact with levodopa or affect your treatment response.
Your healthcare provider will determine the appropriate combination and dosage based on your symptoms and medical needs.
Lodosyn is a prescription medication used together with levodopa to help manage symptoms of Parkinson’s disease and certain forms of parkinsonism.
It helps prevent levodopa from being converted into dopamine before it reaches the brain. This allows more levodopa to enter the brain, where it can help improve movement-related symptoms such as tremors, muscle stiffness, and slow movement.
Lodosyn may also help reduce nausea and vomiting caused by levodopa treatment.
Lodosyn must always be taken with levodopa or a medication containing carbidopa and levodopa. Carbidopa alone does not effectively treat Parkinson’s symptoms.
Lodosyn is available as a 25 mg oral tablet. Take it exactly as prescribed by your healthcare provider.
Your healthcare provider may instruct you to take Lodosyn with one, several, or all of your scheduled levodopa doses.
The appropriate dosage depends on your current medications, treatment response, and the amount of carbidopa you already receive.
The recommended dosage of Lodosyn varies depending on whether you are already taking carbidopa-levodopa or require separate doses of carbidopa and levodopa.
Your healthcare provider will determine your dosage based on your symptoms, medication history, and response to treatment.
Patients Already Taking Carbidopa-Levodopa
Some patients taking a combination medication containing carbidopa and levodopa may not receive enough carbidopa to adequately reduce nausea and vomiting.
In these situations, a healthcare provider may prescribe additional Lodosyn.
According to the prescribing information, patients who need supplemental carbidopa may receive 25 mg of Lodosyn with their first carbidopa-levodopa dose of the day.
Additional doses of 12.5 mg or 25 mg may be prescribed alongside other carbidopa-levodopa doses when necessary.
The amount and frequency depend on the patient’s response and the total amount of carbidopa already included in their combination medication.
Patients Starting Separate Carbidopa and Levodopa Treatment
In certain situations, a healthcare provider may prescribe carbidopa and levodopa as separate medications to allow more individualized dose adjustments.
For patients who require this approach, the recommended starting dose of Lodosyn is generally 25 mg three or four times daily, taken together with levodopa.
However, this starting schedule does not apply to everyone beginning Parkinson’s treatment. Many patients instead begin treatment with a combination carbidopa-levodopa product.
The healthcare provider will adjust the doses according to symptom control, medication tolerance, and any side effects.
Maximum Daily Dosage
According to the official Lodosyn prescribing information, the total daily amount of carbidopa should generally not exceed 200 mg.
This includes carbidopa taken separately as Lodosyn and carbidopa already contained in combination medications.
For example, if you take a carbidopa-levodopa tablet, the carbidopa in that tablet must be included when calculating your total daily dose.
Do not adjust your carbidopa or levodopa doses without consulting your healthcare provider.Â
Lodosyn is taken by mouth with levodopa according to a schedule established by your healthcare provider.
Carbidopa helps reduce the conversion of levodopa into dopamine outside the brain. This allows more levodopa to reach the central nervous system.
Your healthcare provider may instruct you to take Lodosyn at the same time as your levodopa or carbidopa-levodopa medication.
For some patients, additional carbidopa is needed only with certain doses. Others may require it with several doses throughout the day.
The exact schedule depends on the amount of levodopa you take and how well you tolerate treatment.
Take your medications at the prescribed times, and do not change the combination or timing without medical advice.
If your healthcare provider changes your medication schedule, ask them to explain when each tablet should be taken.
Lodosyn can generally be taken with or without food.
However, food may affect how quickly levodopa is absorbed and how well it works.
Some people experience nausea when taking Parkinson’s medication on an empty stomach.
If this occurs, your healthcare provider may recommend taking your medication with a small snack.
Large meals, particularly those high in protein, may interfere with levodopa absorption in some patients.
Protein contains amino acids that can compete with levodopa for transport through the digestive system and into the brain.
This may cause levodopa to work more slowly or less effectively in certain individuals.
If you notice that your Parkinson’s symptoms become worse after meals, tell your healthcare provider.
They may recommend adjusting the timing of your medication in relation to meals.
Do not make major changes to your diet or medication schedule without medical guidance.
Taking Lodosyn consistently helps maintain a reliable treatment routine.
Parkinson’s medications often need to be taken at specific times throughout the day to help control movement-related symptoms.
Because Lodosyn is intended to improve the effectiveness and tolerability of levodopa, it is important to coordinate its timing with your prescribed levodopa doses.
Missing doses or taking medications at inconsistent times may affect how well your Parkinson’s symptoms are controlled.
For example, you may notice increased muscle stiffness, tremors, or difficulty moving if your levodopa treatment is delayed.
Try to take Lodosyn at the same scheduled times each day.
You may find it helpful to use a medication organizer, phone reminder, or written treatment schedule.
If you take several Parkinson’s medications, ask your pharmacist to help you create a clear medication schedule.
Some people taking levodopa experience a wearing-off effect.
This occurs when the medication’s benefits begin to fade before the next scheduled dose.
As levodopa levels decrease, Parkinson’s symptoms may gradually return.
For example, a person may notice increased tremors, stiffness, or difficulty walking shortly before their next dose.
Wearing-off symptoms may become more noticeable as Parkinson’s disease progresses.
If you experience wearing-off, contact your healthcare provider.
They may recommend adjusting your levodopa dose, changing the timing of medication, or considering another Parkinson’s treatment.
Although Lodosyn helps more levodopa reach the brain, adding carbidopa does not necessarily eliminate wearing-off symptoms.
Do not take extra Lodosyn or levodopa to manage wearing-off without medical instructions.
The on-off effect refers to sudden changes in movement control during levodopa treatment.
During an “on” period, levodopa is working effectively, and movement symptoms are better controlled.
During an “off” period, the medication’s effects decrease, causing symptoms such as stiffness, tremors, or difficulty moving to return.
These changes may happen unexpectedly and can interfere with daily activities.
Some people experience sudden difficulty walking or initiating movement during off periods.
If these fluctuations occur, tell your healthcare provider.
Your healthcare provider may review your medication schedule and determine whether changes to your levodopa treatment are necessary.
The official Lodosyn prescribing information notes that adding carbidopa has not been shown to reliably improve markedly irregular on-off responses to levodopa.Â
If you forget to take Lodosyn, contact your healthcare provider or pharmacist if you are unsure how to manage the missed dose.
In general, a missed dose may be taken when remembered if it is not close to the next scheduled dose.
If your next dose is approaching, the missed dose is usually skipped, and treatment continues according to the regular schedule.
However, Lodosyn is taken together with levodopa, so the correct action may depend on whether you also missed the corresponding levodopa dose.
Do not take extra Lodosyn tablets or double your dose to make up for a missed dose.
Taking additional medication without instructions may increase the risk of unwanted effects.
If you frequently miss doses, consider setting reminders or asking your pharmacist for assistance with medication organization.
Do not suddenly stop taking Lodosyn or your levodopa-containing medication without consulting your healthcare provider.
Parkinson’s medications help maintain dopamine activity in the brain.
Abruptly reducing or discontinuing levodopa treatment may cause Parkinson’s symptoms to worsen significantly.
In rare cases, sudden withdrawal or substantial dose reduction can trigger a serious reaction resembling neuroleptic malignant syndrome.
Possible symptoms include severe muscle stiffness, high fever, confusion, changes in blood pressure, and a rapid heartbeat.
This condition requires immediate medical attention.
If your healthcare provider decides that treatment should be stopped or changed, they will determine a safe adjustment plan.
Never discontinue or substantially reduce your Parkinson’s medications independently.
Contact your healthcare provider if your Parkinson’s symptoms become more difficult to control while taking Lodosyn and levodopa.
Worsening symptoms may include increased tremors, muscle stiffness, slower movement, difficulty walking, or more frequent off periods.
Your healthcare provider may review your treatment schedule, medication doses, and possible interactions.
They may also assess whether your symptoms are related to disease progression or changes in your response to levodopa.
Do not increase your medication doses without medical advice.
Keeping a daily record of your symptoms, medication times, and any noticeable wearing-off periods may help your healthcare provider identify patterns.
Lodosyn should only be taken with levodopa or a carbidopa-levodopa medication.
Tell your healthcare provider if you have a history of heart disease, irregular heartbeat, glaucoma, liver disease, kidney disease, or other significant medical conditions.
Parkinson’s treatments containing levodopa may cause dizziness, low blood pressure when standing, involuntary movements, hallucinations, or sudden sleepiness.
Carbidopa may increase the amount of levodopa reaching the brain, so some levodopa-related side effects may become more noticeable after treatment adjustments.
Tell your healthcare provider if you develop unusual movements, confusion, hallucinations, or excessive daytime sleepiness.
Avoid driving or operating dangerous machinery if your medication causes sudden sleepiness or affects your alertness.
Your healthcare provider should also review your other medications because certain drugs may interfere with levodopa treatment.
Contact your healthcare provider if you experience persistent nausea, worsening Parkinson’s symptoms, unusual involuntary movements, or significant dizziness.
Seek prompt medical advice if you develop hallucinations, confusion, or sudden episodes of falling asleep during daily activities.
Seek emergency medical attention if you develop severe muscle stiffness, high fever, confusion, or other serious symptoms after abruptly stopping or reducing Parkinson’s medication.
These symptoms may indicate a potentially life-threatening withdrawal-related reaction.
Lodosyn (Carbidopa) is available in the following forms and strength:
Lodosyn is a prescription medication used with levodopa to treat symptoms of Parkinson’s disease and certain forms of parkinsonism.
It works by preventing levodopa from being converted into dopamine outside the brain. This allows more levodopa to reach the brain, where it can help improve movement-related symptoms such as tremors, muscle stiffness, and slow movement.
Lodosyn may also help reduce nausea and vomiting associated with levodopa therapy.
Although Lodosyn can improve the effectiveness of levodopa, the combination may cause side effects or require additional precautions in people with certain medical conditions.
Many of the warnings associated with Lodosyn are related to its combined use with levodopa rather than carbidopa alone.
Before starting treatment, tell your healthcare provider about your medical history, existing health conditions, and all medications you currently take.
Tell your healthcare provider if you have liver disease or a history of liver problems before taking Lodosyn.
The liver plays an important role in processing medications and removing certain substances from the bloodstream.
Although Lodosyn primarily affects the conversion of levodopa outside the brain, patients with significant liver impairment may require closer monitoring during treatment.
Changes in liver function tests have been reported in patients receiving carbidopa with levodopa.
These tests measure substances in the blood, including liver enzymes, that may help identify liver irritation or injury.
Your healthcare provider may recommend periodic liver function tests, especially if you have a history of liver disease or require long-term treatment.
Possible warning signs of liver problems include unusual fatigue, persistent nausea, loss of appetite, dark urine, and yellowing of the skin or eyes.
Yellowing of the skin or eyes is called jaundice and may indicate impaired liver function.
Contact your healthcare provider promptly if you experience symptoms suggesting liver injury.
Patients with kidney disease should inform their healthcare provider before taking Lodosyn.
The kidneys help filter waste products from the blood and maintain the body’s fluid and electrolyte balance.
Although kidney disease does not automatically prevent Lodosyn treatment, significant kidney impairment may affect the overall safety of a carbidopa-levodopa treatment regimen.
Your healthcare provider may recommend periodic kidney function tests during long-term treatment.
These tests may include blood measurements of creatinine and other indicators of kidney health.
Tell your healthcare provider if you have chronic kidney disease, reduced kidney function, or a history of kidney problems.
Your treatment may require additional monitoring depending on your medical history and other medications.
Older adults may be more sensitive to certain effects of Parkinson’s medications.
As people age, kidney, liver, and cardiovascular function may change. Older adults are also more likely to take several medications for different health conditions.
These factors can increase the risk of medication interactions and unwanted side effects.
When Lodosyn is taken with levodopa, some older patients may experience dizziness, low blood pressure, confusion, hallucinations, or involuntary movements.
These effects may increase the risk of falls or interfere with daily activities.
Your healthcare provider will consider your age, medical history, current medications, and response to treatment when determining the appropriate dosage.
Older adults may require closer monitoring, particularly when treatment is started or adjusted.
Do not change your medication dose based on age alone. Your healthcare provider will determine whether adjustments are necessary.
Tell your healthcare provider if you have a history of depression or other psychiatric conditions before starting Lodosyn.
Parkinson’s disease itself can affect mood, emotions, sleep, and behavior.
In addition, medications that influence dopamine activity in the brain may contribute to changes in mood or behavior in some patients.
Depression, sometimes accompanied by suicidal thoughts, has been reported in patients receiving carbidopa and levodopa.
Possible symptoms include persistent sadness, loss of interest in activities, unusual irritability, sleep disturbances, and changes in appetite.
Some people may also experience anxiety, agitation, or changes in emotional well-being.
A history of depression does not automatically mean that Lodosyn cannot be used. However, additional monitoring may be necessary.
Tell your healthcare provider if you experience new or worsening mood symptoms after starting treatment.
Your healthcare provider can assess whether the symptoms may be related to Parkinson’s disease, medication effects, or another medical condition.
Seek urgent professional help if you experience thoughts of self-harm or suicide.
Lodosyn, when taken with levodopa, may cause drowsiness or excessive daytime sleepiness.
Some patients may feel unusually tired, have difficulty staying awake, or become sleepy during normal activities.
In certain cases, patients taking dopaminergic medications have reported suddenly falling asleep without noticeable warning signs.
These episodes may occur during activities such as eating, talking, watching television, or driving.
Sudden sleep episodes can be dangerous because they may lead to accidents or injuries.
The risk may increase if you take other medications that cause drowsiness or have an existing sleep disorder.
Do not drive, operate heavy machinery, or perform potentially dangerous activities if you experience significant sleepiness or sudden episodes of falling asleep.
Contact your healthcare provider if you notice excessive daytime sleepiness or unexpected sleep episodes.
Your healthcare provider may review your medications and determine whether changes to your treatment are necessary.Â
Lodosyn used with levodopa may cause dizziness or changes in blood pressure.
One possible effect is orthostatic hypotension, which occurs when blood pressure drops after standing up from a sitting or lying position.
This can temporarily reduce blood flow to the brain, causing dizziness, lightheadedness, blurred vision, or fainting.
Some patients may notice these symptoms when getting out of bed or standing after sitting for a long time.
Orthostatic hypotension can increase the risk of falls, particularly in older adults or people with balance difficulties.
To reduce the risk of dizziness, stand up slowly and allow yourself time to regain your balance before walking.
If you frequently feel dizzy or faint, contact your healthcare provider.
Your healthcare provider may recommend checking your blood pressure while sitting and standing.
Do not stop or change your medication without medical advice.
Tell your healthcare provider if you have a history of heart disease or other cardiovascular problems before taking Lodosyn with levodopa.
Cardiovascular disease affects the heart and blood vessels and may include conditions such as coronary artery disease, irregular heart rhythms, and heart failure.
Levodopa-containing treatment may affect blood pressure and heart function in some patients.
Possible effects include palpitations, irregular heartbeats, dizziness, or changes in blood pressure.
Patients who have experienced a heart attack and continue to have certain abnormal heart rhythms may require particularly careful monitoring when treatment is started or adjusted.
Your healthcare provider may recommend monitoring your blood pressure, heart rate, or cardiac function.
Tell your healthcare provider if you experience frequent palpitations, unusual dizziness, or worsening cardiovascular symptoms.
Seek emergency medical attention if you develop severe chest pain, difficulty breathing, or fainting accompanied by concerning heart symptoms.
Some patients taking Lodosyn with levodopa may experience hallucinations or changes in thinking and behavior.
A hallucination occurs when a person sees, hears, or senses something that is not actually present.
For example, a patient may see people or objects that others cannot see.
Hallucinations may occur because levodopa increases dopamine activity in the brain.
Although this action helps control movement, dopamine also influences perception, thinking, and behavior.
Some patients may develop confusion, unusual dreams, paranoia, or delusions.
A delusion is a strongly held belief that does not reflect reality.
These effects may be more concerning in older adults or people with existing cognitive difficulties.
If you or a caregiver notices new hallucinations, confusion, or unusual behavior, contact your healthcare provider promptly.
Your healthcare provider may review your medication doses and determine whether an adjustment is appropriate.
Do not independently stop your Parkinson’s medications.
Lodosyn may contribute to the development of dyskinesia when taken with levodopa.
Dyskinesia refers to involuntary movements that a person cannot easily control.
These movements may include twisting, writhing, twitching, or repetitive motions involving the face, arms, legs, or other parts of the body.
Dyskinesia is primarily associated with levodopa treatment and changes in dopamine activity.
Because carbidopa allows more levodopa to reach the brain, dyskinesias may develop at lower levodopa doses or appear sooner than when levodopa is used without carbidopa.
The severity of dyskinesia may vary.
Some patients experience mild movements that do not interfere with daily activities, while others develop more noticeable or uncomfortable symptoms.
Tell your healthcare provider if you notice new or worsening involuntary movements.
Your healthcare provider may recommend adjusting your levodopa dose or changing your treatment schedule.
Do not increase or decrease Lodosyn or levodopa without medical instructions.Â
Do not suddenly stop taking Lodosyn or your levodopa-containing medication without consulting your healthcare provider.
Parkinson’s medications help maintain dopamine activity in the brain.
Abruptly reducing or discontinuing levodopa treatment may cause movement-related symptoms to worsen significantly.
In rare cases, sudden withdrawal or substantial dose reduction may trigger a serious reaction resembling neuroleptic malignant syndrome.
This condition can cause high fever, severe muscle stiffness, confusion, changes in blood pressure, and a rapid heartbeat.
It requires immediate medical attention.
If your healthcare provider decides to stop or change your medication, they will determine an appropriate adjustment schedule.
Seek emergency medical attention if you develop severe muscle stiffness, high fever, or confusion after reducing or stopping Parkinson’s medication.
Lodosyn may interact with certain medications when taken with levodopa or carbidopa-levodopa products.
Some medications can change how levodopa works, while others may increase the risk of low blood pressure, dizziness, or other unwanted effects.
Important interactions include:
Certain antibiotics may also require review, but not all antibiotics have a clinically important interaction with Lodosyn.
Tell your healthcare provider about all prescription medications, over-the-counter drugs, vitamins, and herbal supplements you take.
Do not begin a new medication without checking whether it may interact with your Parkinson’s treatment.
Tell your healthcare provider if you have a history of asthma, chronic obstructive pulmonary disease (COPD), or another significant respiratory condition.
Asthma is a chronic condition that causes inflammation and narrowing of the airways, sometimes leading to wheezing, coughing, and shortness of breath.
Patients with severe respiratory conditions, including bronchial asthma, may require additional caution when receiving carbidopa and levodopa.
However, there is limited evidence that Lodosyn directly causes asthma to worsen in most patients.
The concern is primarily related to the overall safety of levodopa-containing treatment in patients with significant respiratory disease.
Your healthcare provider will review your respiratory condition, current medications, and treatment needs before prescribing Lodosyn.
Contact your healthcare provider if you notice worsening breathing symptoms after starting treatment.
Seek emergency medical attention if you experience severe difficulty breathing.
Some patients receiving Parkinson’s medications that increase dopamine activity may develop unusual urges or compulsive behaviors.
These effects are associated with changes in dopamine signaling in areas of the brain involved in motivation, reward, and behavior.
Possible symptoms include an unusual increase in gambling, shopping, sexual urges, or other repetitive behaviors that become difficult to control.
Patients may not always recognize these changes themselves.
Family members or caregivers may notice the behavior before the patient becomes aware of it.
If you or someone close to you notices new or unusually strong impulses, contact your healthcare provider.
Your healthcare provider may review your treatment and determine whether medication adjustments are necessary.
Do not independently discontinue Parkinson’s medication because of these symptoms.Â
Your healthcare provider may recommend regular medical assessments while you are taking Lodosyn with levodopa.
These appointments help evaluate symptom control, medication tolerance, and any changes in your overall health.
Depending on your medical history, monitoring may include blood pressure measurements, kidney function tests, liver function tests, and assessment of heart function.
Your healthcare provider may also ask about sleepiness, hallucinations, involuntary movements, mood changes, and changes in daily activities.
Tell your healthcare provider if your Parkinson’s symptoms become worse before the next dose or if you experience sudden periods of reduced movement control.
Keeping a record of medication times, symptoms, and side effects may help identify patterns and guide treatment adjustments.
Contact your healthcare provider if you experience persistent dizziness, unusual drowsiness, worsening tremors, involuntary movements, or significant changes in mood or behavior.
Seek prompt medical advice if you develop hallucinations, confusion, or episodes of suddenly falling asleep during normal activities.
Seek emergency medical attention if you develop severe muscle stiffness, high fever, chest pain, difficulty breathing, or a sudden serious change in consciousness.
These symptoms may indicate a potentially serious complication requiring immediate evaluation.
Yes. Lodosyn may contribute to dyskinesia when taken with levodopa. Dyskinesia is a movement disorder that causes involuntary muscle movements. These movements may include twitching, twisting, writhing, or repetitive motions that are difficult to control. Lodosyn works by preventing levodopa from being converted into dopamine outside the brain. This allows more levodopa to reach the brain, where it can help improve Parkinson’s symptoms. However, increased dopamine activity may also contribute to involuntary movements. Dyskinesia is primarily associated with levodopa treatment, particularly with long-term use. Because Lodosyn increases the amount of levodopa reaching the brain, dyskinesia may occur sooner or at lower levodopa doses than when levodopa is taken alone. Symptoms may range from mild movements that do not interfere with daily activities to more noticeable movements that affect walking, eating, or performing everyday tasks. Contact your healthcare provider if you develop new or worsening involuntary movements while taking Lodosyn. Your healthcare provider may recommend adjusting your levodopa dosage or changing your medication schedule to help manage these symptoms. Do not increase, decrease, or stop taking Lodosyn or levodopa without medical advice.Â
Lodosyn begins working after it is absorbed into the body, but the time needed to notice its benefits depends on your levodopa treatment and individual response. Carbidopa helps prevent levodopa from being converted into dopamine before reaching the brain. This allows more levodopa to enter the brain, where it can be converted into dopamine and help control symptoms such as tremors, muscle stiffness, and slow movement. Some people taking immediate-release levodopa may begin noticing improvement in their movement symptoms within approximately 30 minutes to one hour after a dose. However, this timeframe mainly describes the response to levodopa, not a separate symptom-relieving effect of Lodosyn. Lodosyn does not directly treat Parkinson’s symptoms when taken alone. Instead, it improves the effectiveness and tolerability of levodopa treatment. The time needed for symptom improvement may also depend on whether levodopa is taken with food, the type of levodopa formulation, and the severity of Parkinson’s disease. Your healthcare provider may need to adjust your medication schedule to achieve the best balance between symptom control and side effects. If you do not notice improvement or experience worsening symptoms, contact your healthcare provider rather than increasing your dose independently.
Suddenly stopping Lodosyn or the levodopa-containing medication taken with it may cause Parkinson’s symptoms to worsen. Lodosyn is used together with levodopa to help maintain dopamine activity in the brain. When levodopa-containing treatment is abruptly reduced or discontinued, symptoms such as tremors, muscle stiffness, slow movement, and difficulty walking may return or become more severe. In rare cases, sudden withdrawal or substantial dose reduction of carbidopa-levodopa treatment may trigger a serious reaction resembling neuroleptic malignant syndrome. This potentially life-threatening condition may cause severe muscle stiffness, high fever, confusion, a rapid heartbeat, and changes in blood pressure. Do not suddenly stop taking Lodosyn or levodopa without consulting your healthcare provider. If your healthcare provider decides that treatment should be discontinued or changed, they will determine an appropriate dose-adjustment plan. The medication may need to be reduced gradually, depending on your treatment regimen and medical condition. Seek emergency medical attention if you develop high fever, severe muscle stiffness, or confusion after reducing or stopping Parkinson’s medication.Â
The recommended frequency of Lodosyn depends on your levodopa dosage, treatment response, and the amount of carbidopa you already receive from other medications. Lodosyn is available as a 25 mg oral tablet and must be taken with levodopa or a medication containing carbidopa and levodopa. For patients who require individually adjusted doses of carbidopa and levodopa, Lodosyn may be started at 25 mg three or four times daily, taken together with levodopa. However, patients already taking a combination carbidopa-levodopa medication may require additional Lodosyn only with certain doses. For example, your healthcare provider may prescribe 25 mg of Lodosyn with your first carbidopa-levodopa dose of the day. Additional doses may be recommended if necessary. The total amount of carbidopa from Lodosyn and combination medications should generally not exceed 200 mg daily. Lodosyn can usually be taken with or without food. However, the timing of meals, particularly high-protein meals, may affect levodopa absorption and symptom control. Take Lodosyn at the times prescribed by your healthcare provider, coordinating its use with your levodopa schedule. Do not assume that everyone needs Lodosyn three or four times daily. Your healthcare provider will determine the appropriate schedule based on your individual treatment needs.Â
| Generic name: | Carbidopa |
|---|---|
| Formulation: | Tablet |
| Strength(s): | 25mg |
| Quantities Available: | 100 |
Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.
Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.
When ordering Lodosyn (carbidopa) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is common for prescription medications to ensure adequate management of chronic conditions without frequent refills.
Here’s what you need to know:
Dosage and Quantity: Lodosyn is commonly prescribed in dosages of 25 mg, taken three to four times daily. For a 90-day supply, this means you would order up to 360 tablets (90 days x 4 tablets per day).
Yes, we sell carbidopa on our website. You can enjoy low prices when you order through us. To purchase carbidopa, you will need a valid prescription from your healthcare provider. We require this prescription to dispense the medication safely and appropriately. You can submit your prescription by mailing it to us, faxing it, or uploading it through your online account.
Yes, we ship Lodosyn (carbidopa) to both the United States and Puerto Rico.
Watch how Online Pharmacies Canada is helping customers save money on their medications.
Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Lodosyn (Carbidopa). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Lodosyn (Carbidopa).
REVIEWS